Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractOlfactory eavesdropping between two competing stingless bee species    Next AbstractSensor technology and its application in environmental analysis »

mSystems


Title:Pathophysiology of SARS-CoV-2 Infection in the Upper Respiratory Tract and Its Relation to Breath Volatile Organic Compounds
Author(s):Lichtenstein M; Turjerman S; Pinto JM; Barash O; Koren O;
Address:"NanoScent Labs Ltd., Teradyon Industrial Park, Israel. Azriely Faculty of Medicine, Bar-Ilan Universitygrid.22098.31, Safed, Israel. Section of Otolaryngology-Head and Neck Surgery, Biological Sciences Division, The University of Chicago, Chicago, Illinois, USA"
Journal Title:mSystems
Year:2021
Volume:20210727
Issue:4
Page Number:e0010421 -
DOI: 10.1128/mSystems.00104-21
ISSN/ISBN:2379-5077 (Print) 2379-5077 (Electronic) 2379-5077 (Linking)
Abstract:"Among the many products of metabolic processes are volatile organic compounds (VOCs). In the airways, these volatile metabolites are emitted through breathing and thus are easily sampled for analysis. Recent work has connected the functions and structure of the human microbiome with health and disease. Alteration in microbial function in this context can result in differences in metabolite composition, including that of VOCs, presenting the possibility of a new noninvasive method for clinical diagnosis. Screening methods that assess VOCs arising from changes in the airway microbiome could be highly useful in diagnosing viral upper respiratory tract infections (URTIs), e.g., COVID-19, which are highly contagious and have an enormous public health impact worldwide. A rapid noninvasive screening test for URTIs would pose major advantages in containing the disease. As early evidence shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection alters the human microbiome (both in the gut and the respiratory tract), we propose that detection of a VOC signature of an altered nasal microbiome could be fruitful as a rapid noninvasive measure of URTI in general and of SARS-CoV-2 in particular"
Keywords:Covid-19 microbiome severe acute respiratory syndrome coronavirus 2 upper respiratory tract infections volatile organic compounds;
Notes:"PubMed-not-MEDLINELichtenstein, Moria Turjerman, Sondra Pinto, Jayant M Barash, Orna Koren, Omry eng 2021/07/28 mSystems. 2021 Aug 31; 6(4):e0010421. doi: 10.1128/mSystems.00104-21. Epub 2021 Jul 27"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 29-09-2024